Alzeca Biosciences alzeca.com


Alzeca Biosciences develops imaging compounds to diagnose Alzheimer's disease at the earliest stages. Early detection of Alzheimer's is critical as disease pathology begins to accumulate 10+ years prior to cognitive onset of the disease. As a result, early detection of Alzheimer's pathology offers the patient an opportunity to take counteractive measures at a point where the disease may still be treatable.

Alzeca Biosciences develops imaging compounds to diagnose Alzheimer's disease at the earliest stages. Early detection of Alzheimer's is critical as disease pathology begins to accumulate 10+ years prior to cognitive onset of the disease. As a result,...Show all

Company (Alive / Active)

Phone:

Fax:

1800 Bering Drive
#430
Houston, 77057
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Alzeca Biosciences $11M Aug 17, 2017
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Alzeca Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors

Board Members

Competitors

Company Status Description Investors

Satoris

Redwood City, California, United States
Alive / ActiveSatoris develops tests for neurological diseases such as Alzheimer's, Parkinson's, Multiple Sclerosis, and Diabetic Neuropathy. The company is developing and commercializing neurodiagnostic tests that aim to yield the earliest, most accurate, and most clinically relevant diagnoses, so that healthcare costs can be reduced while patient care becomes even more effective.Login to see details

Avid Radiopharmaceuticals

Philadelphia, Pennsylvania, United States
AcquiredAvid is a clinical-stage product-focused molecular imaging company with IP in the field of molecular brain imaging. Per the company, Avid has developed targeting agents to image amyloid plaques and aims to leverage these compounds for the detection of Alzheimer's disease. Avid is also developing agents targeted to the vesicular monoamine transporter (VMAT-2) to image pathology in dementia with Lewy bodies (DLB), Parkinson's disease (PD), and is also involved in research related to diabetes mel...Show allLogin to see details
See all 17 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Lipid-based nanoparticles Oct 30, 2017 Application